Raised C-reactive protein levels in patients with recent onset type 1 diabetes
โ Scribed by A. Picardi; M. G. Valorani; U. Vespasiani Gentilucci; S. Manfrini; O. Ciofini; M. Cappa; C. Guglielmi; P. Pozzilli
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 87 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1520-7552
- DOI
- 10.1002/dmrr.671
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The aim of this retrospective cohort study is to assess the cumulative development incidence and predictive factors for type 2 diabetes (T2DM) in HCV positive and hypertensive patients treated with losartan. Eighty Japanese patients were given 50 mg of losartan per day after diagnosis of hypertensio
Background Intensive insulin therapy is the gold standard by which Type 1 diabetes is treated. In addition to this therapy, administration of nicotinamide (NA) can be beneยฎcial. This concept is reinforced by the results of a recent meta-analysis of the use of NA in patients with recent-onset Type 1
## Abstract Diabetic hyperglycemia is associated with increased production of reactive oxygen species (ROS). ROS reacts with DNA resulting in various products, such as 8โhydroxydeoxyguanosine (8โOHdG), that excrete in urine owing to DNA repair processes. Urinary 8โOHdG has been proposed as an indic